Toggle navigation
Home
Search
Services
Blog
Contact
About
Japanese Encephalitis Vaccine From Mutated Cdna Clone
Monath, Thomas P.
Acambis, Inc., Cambridge, MA, United States
Search 10 grants from Thomas Monath
Search grants from Acambis, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Structurally dissecting APOBEC3's for HIV-1 restriction and beyond
Eliminating anesthesia confounds in experimental stroke
Elucidating the Role of the Intestinal Microbiota in Pathogen Resistance
Subcellular Regulation of Autophagic Flux in Cardiomyocytes and the Heart
Defining Diet Related Breast Cancer Risks in Black Women
Recently added grants:
Immigrant enclaves: Conferring health advantages or creating health disparities in Chinese immigrants?
International Conferences on Fetal Alcohol Spectrum Disorder
Influence of Strategy Training on Disability for Older Adults with Mild Cognitive Impairment
Race/Ethnic Differences in Life Course Exposure to Death: Consequences for Health
Adolescent Alcohol Abuse, Traumatic Stress, and Vulnerability to Development of PTSD
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AI036798-02
Application #
2073277
Study Section
Special Emphasis Panel (ZRG7-SSS-4 (02))
Project Start
1994-08-01
Project End
1998-05-31
Budget Start
1996-06-01
Budget End
1997-05-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Acambis, Inc.
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02139
Related projects
NIH 1997
R44 AI
Japanese Encephalitis Vaccine From Mutated Cdna Clone
Monath, Thomas P. / Acambis, Inc.
NIH 1996
R44 AI
Japanese Encephalitis Vaccine From Mutated Cdna Clone
Monath, Thomas P. / Acambis, Inc.
Comments
Be the first to comment on Thomas Monath's grant